Sign in
ICAD Stock Price, Chart, Stats & News
iCAD, Inc.
Save
iCAD, Inc. (ICAD) does not currently pay a dividend.
106.31M
Market cap
–
Current P/E
–
Forward P/E
ICAD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 86.16% |
Operating margin | -27.65% |
Pretax margin | -23.47% |
Net margin | -24.06% |
Effective tax rate | -2.50% |
ROA | -8.84% |
ROE | -11.78% |
D/E | 0.01x |
Interest coverage ratio | -334.08x |
ICAD valuation
P/E | – |
P/S | 7.33x |
P/B | 3.36x |
P/CF | -37.26x |
P/FCF | -35.57x |
P/OCF | -37.26x |
PEG | -6.22x |
EV multiple | -38.36x |
About
iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While primarily operating in the United States, the company also maintains a significant international presence. Its operations are organized into two principal divisions: Cancer Detection and Cancer Therapy.
Similar securities
Based on sector and market capitalization
Report issue